Heart Diseases

Widely used heart disease risk calculators may be failing to identify a large proportion of Indians at risk, with nearly 80 per cent of patients who eventually suffered a heart attack not being classified as 'high-risk' beforehand, according to new research. The research titled "Comparison of ASCVD Risk Prediction Models in STEMI: Insights from a South Asian Cohort" was conducted by a team of scientists from Govind Ballabh Pant Institute of Postgraduate Medical Education and Research, ESIC Medical College, Faridabad, the Delhi Cancer Registry at AIIMS, among others. The study, conducted on 4,975 patients with first-time heart attacks, found significant differences in how five major global risk prediction models categorised individuals, raising concerns over their reliability for South Asian populations. Researchers compared widely used tools such as the Framingham Risk Score (FRS), ACC/AHA ASCVD 2013 model, WHO risk charts, JBS-3 calculator and the newer Predicting Risk of ...

A global study reveals how everyday diet choices, including low intake of whole foods and high sodium consumption, are contributing to millions of heart disease deaths worldwide

Eleven medical organisations advised changes to preventive cardiac care that it says could markedly reduce heart attacks and strokes

A massive study of nearly one million US veterans finds that having both insomnia and sleep apnea sharply raises the risk of hypertension and cardiovascular disease

Strong relationships may help reduce stress, regulate blood pressure and support heart health. Experts explain why staying socially connected matters for long-term wellbeing

A long-term US study tracking young adults for more than 30 years shows men develop heart disease up to a decade earlier than women, with cardiovascular risks diverging sharply from the mid-30s

A new human heart study shows type 2 diabetes does not just raise cardiac risk but physically alters heart muscle, energy use and structure, helping explain why heart failure is so common in diabetes

From food packaging to drinking water, microplastics are almost impossible to avoid. A new study suggests these particles can lodge in blood vessels and accelerate artery damage linked to heart diseas

Sudden heart deaths in 'fit-looking' adults under 45 are often linked to silent coronary artery disease. An Apollo doctor explains why it hides, what raises risk, and what checks help

Even smoking two cigarettes a day can stiffen blood vessels, raise clotting, sharply increase the risk of heart failure and early death, new global research warns about the dangers of 'light' smoking

While protein is vital for muscle and metabolism, excessive intake, especially from red and processed meats, may put your kidneys, heart, and even cancer risk on the line, experts caution.

Cardiologist Dr Dmitry Yaranov warns that habits like poor sleep, stress, and pollution can silently damage heart health-even in those who appear fit and healthy, leading to early heart failure

AQI 50, a figure Delhiites can only dream of, still isn't pure air. Doctor explains how even at this level, your body works to counter invisible pollutants

A new study reveals that nearly everyone who suffers a heart attack or stroke had warning signs long before, but most never noticed them

Experts explain why red wine, thin bodies, exercise and fish oil are not foolproof heart protectors and how lifestyle still matters most at every age

Bristol Myers Squibb (BMS) on Wednesday announced the launch of Kopozgo (Mavacamten), an oral, selective cardiac myosin inhibitor, in India. Kopozgo is the first and only oral, selective cardiac myosin inhibitor approved in India for the treatment of adults with symptomatic obstructive hypertrophic cardiomyopathy (oHCM), BMS said in a statement. Mavacamten was approved by the Central Drugs Standard Control Organisation (CDSCO), with an import license issued on March 6, 2025. "Kopozgo is now available to patients in India. The approval of Kopozgo in India is based on positive efficacy and safety results from two Phase III clinical trials, EXPLORER-HCM and VALOR-HCM," the statement said. Sanjay Sharma, General Manager and Managing Director, BMS India, mentioned, "This breakthrough brings hope to individuals and families facing this condition, giving clinicians a novel therapy to address the unmet need in treatment. Bristol Myers Squibb is committed to advancing cardiovascular care fo

Stress, caffeine, and long work hours can make your heart race, but doctors explain when it crosses the line into arrhythmia and how it may trigger sudden cardiac arrest

Daily cocoa extract supplements lowered inflammation markers and cut cardiovascular deaths by 27 per cent in a large trial, raising hopes for its role in healthy ageing

Once seen as a disease of the elderly, heart attacks are now striking 20- and 30-year-olds, making World Heart Day 2025 a wake-up call for urgent action

Over the past decade, India's cardiovascular device market has grown into a significant health-tech segment with an estimated value of $1.55 bn and projected to reach $2.34 bn by 2030